Market News

Bruce & Co Holds Holding in Valeant (VRX); Sheets Smith Wealth Management Cut Position in Stericycle (SRCL) as Stock Price Declined

Stericycle, Inc. (NASDAQ:SRCL) Logo

Bruce & Co Inc increased its stake in Valeant (VRX) by 3.1% based on its latest 2017Q4 regulatory filing with the SEC. Bruce & Co Inc bought 18,000 shares as the company’s stock declined 28.77% with the market. The institutional investor held 599,000 shares of the health care company at the end of 2017Q4, valued at $12.45 million, up from 581,000 at the end of the previous reported quarter. Bruce & Co Inc who had been investing in Valeant for a number of months, seems to be bullish on the $6.12B market cap company. The stock increased 2.10% or $0.36 during the last trading session, reaching $17.54. About 6.39M shares traded. Valeant Pharmaceuticals International, Inc. (NYSE:VRX) has risen 42.00% since April 24, 2017 and is uptrending. It has outperformed by 30.45% the S&P500.

Sheets Smith Wealth Management decreased its stake in Stericycle Inc (SRCL) by 63.83% based on its latest 2017Q4 regulatory filing with the SEC. Sheets Smith Wealth Management sold 32,875 shares as the company’s stock declined 13.72% with the market. The institutional investor held 18,625 shares of the basic industries company at the end of 2017Q4, valued at $1.27 million, down from 51,500 at the end of the previous reported quarter. Sheets Smith Wealth Management who had been investing in Stericycle Inc for a number of months, seems to be less bullish one the $5.22B market cap company. The stock increased 1.04% or $0.63 during the last trading session, reaching $60.99. About 394,726 shares traded. Stericycle, Inc. (NASDAQ:SRCL) has declined 27.78% since April 24, 2017 and is downtrending. It has underperformed by 39.33% the S&P500.

Among 16 analysts covering Stericycle (NASDAQ:SRCL), 6 have Buy rating, 2 Sell and 8 Hold. Therefore 38% are positive. Stericycle had 57 analyst reports since August 14, 2015 according to SRatingsIntel. The stock of Stericycle, Inc. (NASDAQ:SRCL) earned “Sector Perform” rating by RBC Capital Markets on Monday, November 30. The company was upgraded on Tuesday, February 13 by Robert W. Baird. The stock of Stericycle, Inc. (NASDAQ:SRCL) earned “Underperform” rating by Imperial Capital on Friday, September 9. Imperial Capital maintained the stock with “In-Line” rating in Monday, October 26 report. Stifel Nicolaus maintained Stericycle, Inc. (NASDAQ:SRCL) on Thursday, January 4 with “Buy” rating. The stock has “Neutral” rating by Robert W. Baird on Friday, October 23. The company was maintained on Thursday, September 22 by Wedbush. Jefferies maintained Stericycle, Inc. (NASDAQ:SRCL) on Friday, September 15 with “Buy” rating. The stock of Stericycle, Inc. (NASDAQ:SRCL) has “Hold” rating given on Monday, January 22 by BMO Capital Markets. The rating was maintained by Barrington Research with “Outperform” on Wednesday, February 22.

Since October 30, 2017, it had 1 buying transaction, and 1 sale for $766,975 activity. MILLER MARK C also sold $1.39M worth of Stericycle, Inc. (NASDAQ:SRCL) shares.

Analysts await Stericycle, Inc. (NASDAQ:SRCL) to report earnings on May, 3 after the close. They expect $1.04 earnings per share, down 4.59% or $0.05 from last year’s $1.09 per share. SRCL’s profit will be $88.99M for 14.66 P/E if the $1.04 EPS becomes a reality. After $1.00 actual earnings per share reported by Stericycle, Inc. for the previous quarter, Wall Street now forecasts 4.00% EPS growth.

Investors sentiment decreased to 0.7 in 2017 Q4. Its down 0.19, from 0.89 in 2017Q3. It turned negative, as 75 investors sold SRCL shares while 177 reduced holdings. 50 funds opened positions while 126 raised stakes. 76.99 million shares or 1.32% less from 78.02 million shares in 2017Q3 were reported. Ny State Teachers Retirement Sys holds 0.02% or 141,990 shares in its portfolio. 23,307 are held by Texas Permanent School Fund. Teacher Retirement Sys Of Texas invested in 23,246 shares or 0.01% of the stock. Autus Asset Limited Liability invested 0.55% in Stericycle, Inc. (NASDAQ:SRCL). 40,897 are owned by Buckhead Capital Mngmt Limited Liability. Employees Retirement Of Texas accumulated 5,000 shares. Transamerica Advsr Incorporated has 0% invested in Stericycle, Inc. (NASDAQ:SRCL) for 1 shares. Walleye Trading Limited Liability Corporation accumulated 0% or 7,499 shares. Aperio Gru Limited Liability invested in 17,077 shares. Nelson Van Denburg And Campbell Wealth Mgmt Gru Ltd invested in 0.06% or 3,600 shares. Riverpoint Limited Liability Corp invested in 6,517 shares or 0.03% of the stock. Great West Life Assurance Co Can invested 0.01% of its portfolio in Stericycle, Inc. (NASDAQ:SRCL). Busey Tru, a Illinois-based fund reported 25,797 shares. Invesco Ltd invested in 0.05% or 1.96 million shares. Aviva Public Lc reported 0.05% of its portfolio in Stericycle, Inc. (NASDAQ:SRCL).

Sheets Smith Wealth Management, which manages about $700.54 million and $424.21 million US Long portfolio, upped its stake in Schwab Strategic Tr (SCHF) by 15,176 shares to 35,985 shares, valued at $1.23M in 2017Q4, according to the filing. It also increased its holding in Bank Amer Corp (NYSE:BAC) by 14,225 shares in the quarter, for a total of 65,097 shares, and has risen its stake in Laboratory Corp Amer Hldgs (NYSE:LH).

Investors sentiment decreased to 0.97 in 2017 Q4. Its down 0.02, from 0.99 in 2017Q3. It dived, as 51 investors sold VRX shares while 74 reduced holdings. 54 funds opened positions while 67 raised stakes. 169.66 million shares or 0.12% less from 169.87 million shares in 2017Q3 were reported. Alphamark Ltd has invested 0% in Valeant Pharmaceuticals International, Inc. (NYSE:VRX). Howe And Rusling invested in 300 shares. Renaissance Technologies Lc holds 0.24% of its portfolio in Valeant Pharmaceuticals International, Inc. (NYSE:VRX) for 10.65M shares. Cohen Klingenstein Ltd Llc reported 16,738 shares. Parametric Portfolio Associate Ltd Liability Company has 1.29M shares. Prudential Public Limited Liability accumulated 290,714 shares. Fiera accumulated 55,017 shares or 0.01% of the stock. Private Group invested in 1.26M shares or 1.34% of the stock. Perceptive Advsr Ltd Limited Liability Company invested in 30,092 shares. Tekla Cap Ltd Llc holds 0.15% of its portfolio in Valeant Pharmaceuticals International, Inc. (NYSE:VRX) for 192,000 shares. Morgan Stanley stated it has 0.03% of its portfolio in Valeant Pharmaceuticals International, Inc. (NYSE:VRX). Northwestern Mutual Wealth Management Company invested 0.01% in Valeant Pharmaceuticals International, Inc. (NYSE:VRX). Baystate Wealth Mngmt accumulated 149 shares. Commonwealth Bancshares Of Aus reported 166,495 shares. Horizon Kinetics Limited Liability accumulated 0.01% or 22,739 shares.

Bruce & Co Inc, which manages about $644.66M and $461.44 million US Long portfolio, decreased its stake in Amerco (NASDAQ:UHAL) by 2,401 shares to 185,969 shares, valued at $70.28M in 2017Q4, according to the filing.

Among 28 analysts covering Valeant Pharmaceuticals Intl (NYSE:VRX), 7 have Buy rating, 5 Sell and 16 Hold. Therefore 25% are positive. Valeant Pharmaceuticals Intl had 162 analyst reports since July 21, 2015 according to SRatingsIntel. The company was downgraded on Thursday, December 14 by JP Morgan. The rating was downgraded by Nomura on Wednesday, March 16 to “Neutral”. The stock has “Overweight” rating by Morgan Stanley on Thursday, November 10. The stock of Valeant Pharmaceuticals International, Inc. (NYSE:VRX) earned “Hold” rating by BMO Capital Markets on Friday, September 29. The firm earned “Hold” rating on Monday, September 18 by H.C. Wainwright. The stock of Valeant Pharmaceuticals International, Inc. (NYSE:VRX) has “Buy” rating given on Friday, November 20 by Mizuho. The stock of Valeant Pharmaceuticals International, Inc. (NYSE:VRX) has “Neutral” rating given on Monday, August 15 by Mizuho. Barclays Capital maintained Valeant Pharmaceuticals International, Inc. (NYSE:VRX) on Thursday, May 11 with “Equal Weight” rating. Jefferies maintained Valeant Pharmaceuticals International, Inc. (NYSE:VRX) rating on Wednesday, September 13. Jefferies has “Buy” rating and $18.0 target. The firm has “Sector Outperform” rating by Scotia Capital given on Wednesday, October 14.

Since March 8, 2018, it had 3 insider purchases, and 0 selling transactions for $876,370 activity. Herendeen Paul bought 15,000 shares worth $241,470. On Tuesday, March 13 PAPA JOSEPH C bought $481,500 worth of Valeant Pharmaceuticals International, Inc. (NYSE:VRX) or 30,000 shares.

Stericycle, Inc. (NASDAQ:SRCL) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *